174 related articles for article (PubMed ID: 25810462)
21. Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
Chung TT; Evanson J; Walker D; Akker SA; Besser GM; Monson JP; Grossman AB; Drake WM
Clin Endocrinol (Oxf); 2008 Jun; 68(6):965-9. PubMed ID: 18031317
[TBL] [Abstract][Full Text] [Related]
22. Incidence of a second tumor in hypopituitary patients operated for pituitary tumors.
Erfurth EM; Bülow B; Mikoczy Z; Hagmar L
J Clin Endocrinol Metab; 2001 Feb; 86(2):659-62. PubMed ID: 11158027
[TBL] [Abstract][Full Text] [Related]
23. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
Losa M; Gatti E; Rossini A; Lanzi R
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
[TBL] [Abstract][Full Text] [Related]
24. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
25. Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study.
Buchfelder M; Kann PH; Wüster C; Tuschy U; Saller B; Brabant G; Kleindienst A; Nomikos P;
Eur J Endocrinol; 2007 Aug; 157(2):149-56. PubMed ID: 17656592
[TBL] [Abstract][Full Text] [Related]
26. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis.
Attanasio AF; Jung H; Mo D; Chanson P; Bouillon R; Ho KK; Lamberts SW; Clemmons DR;
J Clin Endocrinol Metab; 2011 Jul; 96(7):2255-61. PubMed ID: 21543424
[TBL] [Abstract][Full Text] [Related]
28. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database.
Attanasio AF; Bates PC; Ho KK; Webb SM; Ross RJ; Strasburger CJ; Bouillon R; Crowe B; Selander K; Valle D; Lamberts SW;
J Clin Endocrinol Metab; 2002 Apr; 87(4):1600-6. PubMed ID: 11932289
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P;
J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679
[TBL] [Abstract][Full Text] [Related]
30. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.
Gardner CJ; Mattsson AF; Daousi C; Korbonits M; Koltowska-Haggstrom M; Cuthbertson DJ
Eur J Endocrinol; 2015 Apr; 172(4):371-81. PubMed ID: 25583905
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
[TBL] [Abstract][Full Text] [Related]
32. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.
Klose M; Jonsson B; Abs R; Popovic V; Koltowska-Häggström M; Saller B; Feldt-Rasmussen U; Kourides I
Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S75-83. PubMed ID: 19684053
[TBL] [Abstract][Full Text] [Related]
33. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
[TBL] [Abstract][Full Text] [Related]
34. Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS).
Mo D; Hardin DS; Erfurth EM; Melmed S
Pituitary; 2014 Oct; 17(5):477-85. PubMed ID: 24122237
[TBL] [Abstract][Full Text] [Related]
35. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract][Full Text] [Related]
36. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.
Verweij T; Slagboom TNA; van Varsseveld NC; van der Lely AJ; Drent ML; van Bunderen CC
Eur J Endocrinol; 2021 Oct; 185(6):793-801. PubMed ID: 34605771
[TBL] [Abstract][Full Text] [Related]
38. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
39. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
[TBL] [Abstract][Full Text] [Related]
40. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
Jasim S; Alahdab F; Ahmed AT; Tamhane SU; Sharma A; Donegan D; Nippoldt TB; Murad MH
Endocrine; 2017 May; 56(2):267-278. PubMed ID: 27815769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
